Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-20-000017

EVP, Chief Financial Officer gave up 610 shares (to pay taxes)

  • EVP, Chief Financial Officer acquired 12,207 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

LINDAHL RICHARD S · EVP, Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-25 Grant or award : show line 1 in the form +6,103 27,040 D
2020-02-25 Grant or award : show line 2 in the form +6,104 33,144 D
2020-02-26 Shares withheld for taxes : show line 3 in the form −610 $59.91 $36,545 32,534 D

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-02-25 Grant or award : show line 4 in the form Employee Stock Options (Right to Buy) +24,414 $61.44 $1,499,996 44,735 D
Loading xslF345X03/wf-form4_158285639623403.xml…